Cosmos Health Inc.
COSM- Exchange
- Nasdaq
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- SEC CIK
- 0001474167
No open-market purchases or sales by Cosmos Health Inc. insiders were filed in the last 90 days; 30 institutions reported holding it in 13F filings for Q3 2026, worth $3.20M in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 1:15 PM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2025: $19.1M (29.3% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K/A |
| Reported | – | – | – | – | – |
| Revenue | $65.3M | $54.4M | $53.4M | $50.3M | $56.2M |
| Cost of revenue | $57.4M | $50.1M | $49.0M | $44.4M | $47.9M |
| Gross profit | $7.90M | $4.31M | $4.35M | $5.96M | $8.33M |
| Operating expenses | $24.6M | $19.9M | $26.2M | $13.4M | $12.9M |
| Research and development | $519.4K | $533.3K | – | – | – |
| Selling, general and administrative | $15.6M | $11.7M | $19.6M | $10.2M | $9.21M |
| Operating income | -$16.7M | -$15.5M | -$21.8M | -$7.47M | -$4.53M |
| Interest expense | $1.90M | $1.01M | $866.5K | $2.35M | $2.82M |
| Income tax | $0 | $0 | – | $775.1K | -$114.0K |
| Net income | -$19.1M | -$16.2M | -$18.5M | -$13.8M | -$7.96M |
| EPS, basic | $-0.63 | $-1.17 | $-2.15 | $-33.16 | $-0.95 |
| EPS, diluted | $-0.63 | $-1.17 | $-2.15 | $-33.16 | $-0.95 |
| Weighted shares, basic | 30.3M | 19.1M | 12.0M | 1.93M | 16.4M |
| Weighted shares, diluted | 30.3M | – | – | 1.93M | 16.4M |
| Margins and growth | |||||
| Gross margin | 12.1% | 7.9% | 8.1% | 11.8% | 14.8% |
| Operating margin | -25.6% | -28.6% | -40.9% | -14.8% | -8.1% |
| Net margin | -29.3% | -29.7% | -34.7% | -27.5% | -14.2% |
| Revenue growth, year over year | +19.9% | +2.0% | +6.0% | −10.5% | +1.5% |
| Net income growth, year over year | – | – | – | – | −1,070.0% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K/A |
| Reported | – | – | – | – | – |
| Cash and equivalents | $715.7K | – | – | $20.7M | $286.5K |
| Short-term investments | $46.2K | $21.1K | $20.1K | $14.9K | $6.70K |
| Accounts receivable | $19.6M | $13.5M | $19.8M | – | – |
| Inventory | $5.78M | $4.36M | $4.79M | $3.45M | $3.15M |
| Total current assets | $38.4M | $25.5M | $36.6M | $56.0M | $40.9M |
| Property, plant and equipment | $10.6M | $9.69M | $10.5M | $1.82M | $1.88M |
| Goodwill | $49.7K | $49.7K | $49.7K | $49.7K | $49.7K |
| Intangible assets | $7.52M | $7.71M | $7.63M | $657.2K | $443.5K |
| Total assets | $65.5M | $54.3M | $66.0M | $68.0M | $49.4M |
| Total current liabilities | $38.3M | $25.8M | $24.3M | $21.7M | $29.9M |
| Long-term debt | $3.78M | $4.11M | $4.61M | $5.02M | $477.6K |
| Total liabilities | $47.1M | $29.8M | $30.0M | $28.4M | $45.0M |
| Shareholders' equity | $18.4M | $24.5M | $36.0M | $39.3M | $4.38M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K/A |
| Reported | – | – | – | – | – |
| Operating cash flow | -$8.45M | -$7.72M | -$15.6M | -$14.9M | -$7.10M |
| Capital expenditures | $55.7K | $418.1K | $1.31M | $74.2K | $581.4K |
| Free cash flow | -$8.50M | -$8.14M | -$16.9M | -$14.9M | -$7.68M |
| Depreciation and amortization | $1.36M | $1.25M | $614.4K | $103.2K | $449.7K |
| Stock-based compensation | $2.31M | $1.69M | $577.9K | $24.4K | – |
| Share buybacks | – | $0 | $100.5K | – | $376.9K |
| Investing cash flow | -$2.01M | -$798.3K | -$13.8M | -$21.5K | -$826.8K |
| Financing cash flow | $14.1M | $5.05M | $12.7M | $35.0M | $7.27M |
| Net change in cash | $3.14M | -$3.52M | -$16.9M | $20.5M | -$341.9K |
| Ratio | |||||
| Stock-based compensation, % of revenue | 3.5% | 3.1% | 1.1% | 0.0% | – |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Aug 18, 2026 | 100.6M | +233.1% | SEC |
| May 18, 2026 | 54.4M | +89.3% | SEC |
| Apr 14, 2026 | 50.8M | +86.3% | SEC |
| Nov 14, 2025 | 34.9M | +49.6% | SEC |
| Aug 14, 2025 | 30.2M | +69.4% | SEC |
| May 15, 2025 | 28.8M | – | SEC |
| Apr 15, 2025 | 27.3M | – | SEC |
| Nov 14, 2024 | 23.3M | +74.2% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.